A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of <10 μm, alginic acid or {TAIL ~ its pharmaceutically acceptable salts} in an amount of 1.5 6.0% by weight, and a superdisintegrant in an amount of at least 6% by {HEAD ~ weight} 
A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of < 10 μm , alginic acid or { TAIL ~ its pharmaceutically acceptable salts } in an amount of 1.5 6.0 % by weight , and a superdisintegrant in an amount of at least 6 % by { HEAD ~ weight }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD